PeptiDream Inc. provided consolidated earnings guidance for the fiscal year ending December 31, 2023. For the year, the company expects revenue of JPY 30,000 million, operating profit of JPY 6,300 million and profit attributable to owners of parent of JPY 2,700 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,966 JPY | -0.48% | -5.55% | +32.22% |
07/05 | Jefferies Adjusts PeptiDream’s Price Target to 1,900 Yen From 1,400 Yen, Keeps at Hold | MT |
30/04 | Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.22% | 1.65B | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- 4587 Stock
- News PeptiDream Inc.
- PeptiDream Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023